Recent Drug Approvals Transforming Oncology Care

Friday, 7 June 2024 | Lung Cancer

The FDA and the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) have approved or recommended a wave of new drugs that are set to transform cancer treatment. These approvals span across various oncological areas, including innovative therapies for solid tumors and hematological cancers. Let’s dive into these newly approved or recommended drugs below.

To continue, please login or sign up first